as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
4.07%
Downside
0.14%
Upside
52 Week's Low
52 Week's High
32.02%
Downside
0.14%
Upside
Check Amgen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$188.3B
EPS (TTM)
21.2828
Dividend Yield
2.63%
Quarterly Earnings Growth YOY
1.12%
PE Ratio (TTM)
27.02
Industry PE ratio
21.402467532467533
PEG Ratio
1.093
EBITDA
17.1B
Revenue (TTM)
36.8B
Profit Margin
19.47%
Return On Equity TTM
81.71%
Track how Amgen Inc. P/E has moved over time to understand its valuation trends.
Amgen Inc. in the last 5 years
Lowest (12.34x)
December 31, 2021
Industry (21.40x)
February 7, 2026
Today (27.02x)
February 7, 2026
Highest (17.02x)
September 30, 2024
Today’s Price to Earnings Ratio: 27.02x
Compare market cap, revenue, PE, and other key metrics of Amgen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $188.3B | 62.63% | 27.02 | 19.47% | |
| BUY | $952.7B | 424.45% | 52.1 | 30.99% | |
| BUY | $390.2B | 105.49% | 167.25 | 4.00% | |
| BUY | $533.6B | 45.93% | 20.08 | 28.46% | |
| BUY | $268.3B | 60.86% | 14.21 | 29.63% |
The Amgen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amgen Inc. investment value today
Current value as on today
₹1,34,540
Returns
₹34,540
(+34.54%)
Returns from Amgen Inc. Stock
₹31,018 (+31.02%)
Dollar Returns*
₹3,522 (+3.52%)
Based on 37 analysts
56.76%
Buy
35.14%
Hold
8.11%
Sell
Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc.. Average target price of $341.93
Get share price movements and forecasts by analysts on Amgen Inc..
What analysts predicted
-12.48%DOWNSIDE
Target Price
$341.93
Current Price
$384.59
Analyzed by
37 Analysts
Target
$341.93
Amgen Inc. target price $341.93, a slight downside of -12.48% compared to current price of $384.59. According to 37 analysts rating.
Investment in Amgen Inc. Shares on INDmoney has grown by 152.77% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:152.77% versus previous 30 day period
Search interest for Amgen Inc. Stock has increased by 146% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:146% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 February
Thu, 10:45 AM
-Amgen's stock shows strong returns; analysts suggest it may be undervalued based on DCF analysis.
Thu, 02:10 PM
-Amgen reports Q4 adjusted earnings of $5.29, beating estimates, shares jump 8.2%.
Thu, 10:24 PM
-CVS Health to replace Amgen's treatments with lower-cost alternatives starting April 1.
Today's Timeline - 05 February
Fri, 00:53 AM
-RBC raises Amgen's price target to $360 after strong Q4 results, driven by key drugs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Amgen Inc. has shown consistent growth in its revenue over the past four quarters. The revenue has increased from $8.14 billion to $9.86 billion, averaging a 6.1% increase each quarter.
Price Rise
![]()
In the last 7 days, AMGN stock has moved up by 11.5%
Best in 3 Years
![]()
In the last 3 years, AMGN has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 56.7% return, outperforming this stock by 25.8%
Profit Down
![]()
Amgen Inc. has experienced a decline in its net profit over the last two quarters. The net profit dropped from $3.21 billion to $1.33 billion, with an average decrease of 58.6% per quarter.
| Organisation | Amgen Inc. |
| Headquarters | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Bradway |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Robert A. Bradway | Chairman & CEO |
Dr. James E. Bradner M.D. | Executive Vice President of Research & Development |
Mr. Scott Skellenger | Senior VP & Chief Information Officer |
Mr. Howard Y. Chang M.D., Ph.D. | Senior VP of Global Research & Chief Scientific Officer |
Casey Capparelli | Executive Director of Investor Relations |
Mr. Peter H. Griffith | Executive VP & CFO |
Dr. David M. Reese M.D. | Executive VP & CTO |
Mr. Murdo Gordon | Executive Vice President of Global Commercial Operations |
Mr. Esteban Santos | Executive Vice President of Operations |
Mr. Matthew C. Busch | Chief Accounting Officer & VP of Finance |
Amgen Inc. share price today is $384.59 as on at the close of the market. Amgen Inc. share today touched a day high of $385.12 and a low of $368.93.
Amgen Inc. share touched a 52 week high of $385.12 on and a 52 week low of $261.43 on . Amgen Inc. stock price today i.e. is closed at $384.59,which is 0.14% down from its 52 week high and 47.11% up from its 52 week low.
Amgen Inc. market capitalisation is $0.19T as on .
Indian investors can start investing in Amgen Inc. (AMGN) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Amgen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amgen Inc. share’s latest price of $384.59 as on February 7, 2026 at 2:29 am IST, you will get 0.0260 shares of Amgen Inc.. Learn more about
fractional shares .
Amgen Inc. stock has given 62.63% share price returns and 23.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?